Journal
LancetPubMed ID
23439101Language
enISSN
1474-547Xae974a485f413a2113503eed53cd6c53
10.1016/S0140-6736(13)60346-3
Scopus Count
Collections
Related articles
- Hepatitis C in 2012: On the fast track towards IFN-free therapy for hepatitis C?
- Authors: Wedemeyer H
- Issue date: 2013 Feb
- Cost-effectiveness of peginterferon alfa-2a (40kDa) plus ribavirin in patients with HIV and hepatitis C virus co-infection.
- Authors: Hornberger J, Torriani FJ, Dieterich DT, Bräu N, Sulkowski MS, Torres MR, Green J, Patel K
- Issue date: 2006 Aug
- Is there discrimination in access to therapy for HCV patients?
- Authors: Garattini S
- Issue date: 2008 Oct
- Care of patients with hepatitis C and HIV co-infection.
- Authors: Soriano V, Puoti M, Sulkowski M, Mauss S, Cacoub P, Cargnel A, Dieterich D, Hatzakis A, Rockstroh J
- Issue date: 2004 Jan 2
- A multidisciplinary support programme increases the efficiency of pegylated interferon alfa-2a and ribavirin in hepatitis C.
- Authors: Carrión JA, Gonzalez-Colominas E, García-Retortillo M, Cañete N, Cirera I, Coll S, Giménez MD, Márquez C, Martin-Escudero V, Castellví P, Navinés R, Castaño JR, Galeras JA, Salas E, Bory F, Martín-Santos R, Solà R
- Issue date: 2013 Nov